Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial. (Q52890142)
Jump to navigation
Jump to search
scientific article published on 17 January 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial. |
scientific article published on 17 January 2012 |
Statements
Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial. (English)
Peter A Fasching
1 reference
Sibylle Loibl
1 reference
Michael Untch
1 reference
Joachim Bischoff
Holger Eidtmann
Manfred Kaufmann
Jens-Uwe Blohmer
Jörn Hilfrich
Dirk Strumberg
Rolf Kreienberg
Hans Tesch
Claus Hanusch
Bernd Gerber
Mahdi Rezai
Christian Jackisch
Jens Huober
Thorsten Kühn
Valentina Nekljudova
Gunter von Minckwitz
German Breast Group (GBG)
Arbeitsgemeinschaft Gynäkologische Onkologie-Breast (AGO-B) Study Group
17 January 2012
13
2
135-144